Pediapharm Inc. (CVE:PDP – Get Free Report)’s share price was up 1.7% on Thursday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a market capitalization of C$66.36 million and a P/E ratio of -4.11. The stock’s 50 day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.30. The company has a debt-to-equity ratio of 186.87, a current ratio of 1.12 and a quick ratio of 0.71.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Recommended Stories
- Five stocks we like better than Pediapharm
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 Leveraged ETFs to Multiply Returns
- What is a Bond Market Holiday? How to Invest and Trade
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What are earnings reports?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
